Human T lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes lifelong T-cell
infection in humans, impacting the host immune response. This virus causes a range of …

Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people
globally and can cause severe and potentially fatal disease, including adult T-cell …

ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …

Human T-cell leukemia virus type 1 (HTLV-1) is a replication-competent human retrovirus
associated with two distinct types of diseases: a malignancy of mature CD4+ T cells called …

Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …

Human T cell leukemia virus type 1 (HTLV-1), the etiological agent of adult T-cell
leukemia/lymphoma (ATLL) and the demyelinating neuroinflammatory disease known as …

Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

Background Human T-cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus that
causes a lifelong infection. Several diseases, including an aggressive form of leukaemia …

Five to ten million individuals are infected by Human T-cell Leukemia Virus type 1 (HTLV-1).
HTLV-1 is transmitted through prolonged breast-feeding, by sexual contacts and by …

HTLV-1 is a retrovirus which causes diverse diseases in 10% of its infected population,
significantly worsening their quality of life and mortality rate. Even though it is globally …